Sapan Gai, CCO at Sovereign Metals, discusses their superior graphite test results. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHammerson Regulatory News (HMSO)

Share Price Information for Hammerson (HMSO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 29.30
Bid: 29.26
Ask: 29.34
Change: 0.42 (1.45%)
Spread: 0.08 (0.273%)
Open: 28.92
High: 29.42
Low: 28.72
Prev. Close: 28.88
HMSO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Indicative Results of Bond Tender Offers

8 Sep 2023 09:00

RNS Number : 8583L
Hammerson PLC
08 September 2023
 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION (EU) 596/2014 AS IT FORMS PART OF DOMESTIC LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018 (EUWA).

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO, OR TO ANY PERSON LOCATED OR RESIDENT IN, OR AT ANY ADDRESS IN, THE UNITED STATES OF AMERICA, ITS TERRITORIES AND POSSESSIONS (INCLUDING PUERTO RICO, THE U.S. VIRGIN ISLANDS, GUAM, AMERICAN SAMOA, WAKE ISLAND AND THE NORTHERN MARIANA ISLANDS), ANY STATE OF THE UNITED STATES OF AMERICA OR THE DISTRICT OF COLUMBIA (THE UNITED STATES) OR TO ANY U.S. PERSON (AS DEFINED IN REGULATION S OF THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE SECURITIES ACT)) OR IN OR INTO ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL TO RELEASE, PUBLISH OR DISTRIBUTE THIS DOCUMENT.

HAMMERSON PLC ANNOUNCES

INDICATIVE RESULTS OF TENDER OFFERS IN RESPECT OF ITS

£350,000,000 3.500 PER CENT. BONDS DUE 2025 (the 2025 BONDS)

AND

£300,000,000 6.00 PER CENT. BONDS DUE 2026 (the 2026 BONDS)

8 September 2023.

Hammerson plc (the Company) announces today the indicative results of its separate invitations to holders of its outstanding (a) £350,000,000 3.500 per cent. Bonds due 2025 (ISIN: XS1311391012) (the 2025 Bonds) and (b) £300,000,000 6.00 per cent. Bonds due 2026 (ISIN: XS0184639895) (the 2026 Bonds and, together with the 2025 Bonds, the Bonds and each a Series) to tender their Bonds for purchase by the Company for cash (each such invitation an Offer and together the Offers).

The Offers were announced on 31 August 2023 and were made on the terms and subject to the conditions contained in the tender offer memorandum dated 31 August 2023 (the Tender Offer Memorandum).

Capitalised terms used in this announcement but not defined have the meanings given to them in the Tender Offer Memorandum.

The Expiration Deadline for the Offers was 4.00 p.m. (London time) on 7 September 2023.

New Issue Condition

The Company confirms that the issue of the New Bonds settled on 6 September 2023, and therefore the New Issue Condition has been satisfied.

Expected Series Acceptance Amounts

As at the Expiration Deadline, the Company had received valid tenders for purchase pursuant to the Offers of (i) £96,114,000 in aggregate nominal amount of 2025 Bonds and (ii) £88,392,000 in aggregate nominal amount of 2026 Bonds.

If the Company decides to accept Bonds validly tendered pursuant to the Offers, the Company expects that each Series Acceptance Amount and applicable Scaling Factor will be set as follows:

Series Expected Series Acceptance Amount Expected Scaling Factor

2025 Bonds £11,700,000 7.055 per cent.

2026 Bonds £88,392,000 N/A

Bondholders should note that this is a non-binding indication of the level at which the Company expects to set each Series Acceptance Amount and applicable Scaling Factor.

Pricing for the Offers will take place at or around 11.00 a.m. (London time) today (the Pricing Time). As soon as reasonably practicable after the Pricing Time, the Company will announce whether it will accept valid tenders of Bonds pursuant to either or both Offers and, if so accepted, the Final Acceptance Amount, each Series Acceptance Amount, each Benchmark Security Rate, each Purchase Yield, each Purchase Price and any Scaling Factors that will be applied to the Bonds of either Series, as applicable.

The Settlement Date in respect of the Bonds accepted for purchase pursuant to the Offers is expected to be 13 September 2023.

Lloyds Bank Corporate Markets plc (Tel: +44 (0) 20 7158 1719/1726; Attn: Liability Management, Commercial Banking; Email: LBCMLiabilityManagement@lloydsbanking.com); and Mizuho International plc (Tel: +44 20 7090 6134; Attn: Liability Management; Email: liabilitymanagement@uk.mizuho-sc.com) are acting as Dealer Managers for the Offers (as made to the Relevant Bondholders).

Kroll Issuer Services Limited (Tel: +44 20 7704 0880; Attn: Alessandro Zorza; Email: hammerson@is.kroll.com) is acting as Tender Agent.

UK MAR: This announcement is released by the Company and contains information that qualified or may have qualified as inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 (MAR) as it forms part of UK domestic law by virtue of the EUWA (UK MAR), encompassing information relating to the Offers described above. For the purposes of UK MAR and Article 2 of the binding technical standards published by the Financial Conduct Authority in relation to MAR as regards Commission Implementing Regulation (EU) 2016/1055, this announcement is made by Alex Dunn, Company Secretary at the Company.

DISCLAIMER This announcement must be read in conjunction with the Tender Offer Memorandum. No offer or invitation to acquire any securities is being made pursuant to this announcement. The distribution of this announcement and the Tender Offer Memorandum in certain jurisdictions may be restricted by law. Persons into whose possession this announcement and/or the Tender Offer Memorandum comes are required by each of the Company, the Dealer Managers and the Tender Agent to inform themselves about, and to observe, any such restrictions.

 

 

This announcement has also been released on the SENS system of the Johannesburg Stock Exchange and on Euronext Dublin.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RTESSWSWAEDSEIU
Date   Source Headline
18th Aug 20233:00 pmRNSHolding(s) in Company
14th Aug 20239:30 amRNSDividend Currency Conversion Announcement
10th Aug 20233:00 pmRNSHolding(s) in Company
27th Jul 20234:30 pmRNSInterim Dividend Record Date Correction
27th Jul 20237:01 amRNSDividend Declaration
27th Jul 20237:00 amRNSHalf-year Report
5th Jul 20237:00 amRNSNotice of Results & IASB Accounting Interpretation
22nd Jun 202311:30 amRNSHolding(s) in Company
22nd Jun 20237:00 amRNSHolding(s) in Company
14th Jun 20239:30 amRNSHolding(s) in Company
12th Jun 20231:15 pmRNSHolding(s) in Company
31st May 20239:00 amRNSBlock listing Interim Review
30th May 202311:30 amRNSHolding(s) in Company
17th May 20239:00 amRNSDirector/PDMR Shareholding
4th May 20234:15 pmRNSResult of AGM
28th Apr 20234:15 pmRNSDirector/PDMR Shareholding
26th Apr 20233:30 pmRNSHolding(s) in Company
25th Apr 20237:00 amRNSPre AGM trading update
17th Apr 20234:00 pmRNSHolding(s) in Company
14th Apr 20239:00 amRNSHolding(s) in Company
13th Apr 20233:00 pmRNSDirector/PDMR Shareholding
3rd Apr 202311:00 amRNSAnnual Report and Notice of Annual General Meeting
3rd Apr 20237:00 amRNSDisposal
21st Mar 20235:15 pmRNSDirector/PDMR Shareholding
10th Mar 202311:45 amRNSHolding(s) in Company
9th Mar 20237:00 amRNSFinal Results
6th Mar 20233:30 pmRNSHolding(s) in Company
22nd Feb 20237:00 amRNSIASB Accounting Interpretation
16th Jan 20233:00 pmRNSNotice of Results and Registered Office Change
30th Nov 202210:00 amRNSBlock listing Interim Review
23rd Nov 202212:45 pmRNSShare capital reduction confirmation
22nd Nov 202212:30 pmRNSHolding(s) in Company
10th Nov 20228:00 amRNSDirector/PDMR Shareholding
8th Nov 20223:45 pmRNSDirector/PDMR Shareholding
8th Nov 20227:00 amRNSQ3 trading, operational and rent collection update
3rd Nov 20227:43 amRNSTotal Voting Rights
3rd Nov 20227:00 amRNS2023 EUR500,000,000 1.750 per cent Bond Redemption
1st Nov 20229:45 amRNSInterim Dividend and Enhanced Scrip Alternative
25th Oct 20222:30 pmRNSResult of General Meeting
19th Oct 202210:45 amRNSBoard Committee Appointment
12th Oct 20227:00 amRNSDirectorate Change
6th Oct 20224:00 pmRNSHolding(s) in Company
6th Oct 202210:00 amRNSCash Fractions for the Enhanced Scrip Dividend
30th Sep 20224:30 pmRNSHolding(s) in Company
28th Sep 202210:00 amRNSCircular, Notice of Meeting and Form of Proxy
27th Sep 20229:30 amRNSCurrency Conversion & Scrip Reference Share Price
14th Sep 20224:00 pmRNSInterim 2022 Dividend Expected Timetable of Events
18th Aug 202212:15 pmRNSHolding(s) in Company
28th Jul 20227:01 amRNSDividend Declaration
28th Jul 20227:00 amRNSHalf-year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.